Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24h after oral administration in dogs

British Journal of Pharmacology

Volumn 141, Issue 4, 2004, Pages 549-551

  Nagy, Orsolya ^a   Hajnal, Ágnes ^a   Parratt, James R ^a   Végh, Ágnes ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Delayed preconditioning; Myocardial ischaemia; Sildenafil; Ventricular arrhythmias; Viagra

Indexed keywords

SILDENAFIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; HEART ARRHYTHMIA; HEART PACING; HEART PROTECTION; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMIC MONITORING; ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; ST SEGMENT; THORACOTOMY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CORONARY VESSELS; DOGS; ELECTROCARDIOGRAPHY; HEMODYNAMIC PROCESSES; MYOCARDIAL REPERFUSION INJURY; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 1842610702     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705658     Document Type: Article

References (17)

1. BABAI, L., SZIGETI, Z., PARRATT, J.R. & VÉGH, Á. (2002). Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible role of nitric oxide. Clin. Sci., 102, 435-445.
2. CHEITLIN, M.D., HUTTER, A.M., BRINDIS, R.G., GANZ, P., KAUL, S., RUSSELL, R.O. & ZUSMAN, R.M. (1999). Use of sildenafil (Viagra) in patients with cardiovascular disease. J. Am. Coll. Cardiol., 33, 273-282.
3. GEELEN, P., DROLET, B., RAIL, J., BERUBE, J., DALEAU, P., ROUSSEAU, G., CARDINAL, R., O'HARA, G.E. & TURGEON, J. (2000). Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation, 102, 275-277.
4. GRESSER, U. & GLEITER, C.H. (2002). Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil. Review of the literature. Eur. J. Med. Res., 7, 435-446.
5. KIS, A., VÉGH, Á., PAPP, J.G. & PARRATT, J.R. (1999). Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. Br. J. Pharmacol., 127, 1545-1550.
6. KODANI, E., XUAN, Y.-T., TAKANO, H., SHINMURA, K., TANG, X.-L. & BOLLI, R. (2002). Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits. Circulation, 105, 3046-3052.
7. ATP channels in rabbits. Am. J. Physiol., 283, H1263-H1289.
8. PARRATT, J.R. & VÉGH, Á. (1997). Delayed protection against ventricular arrhythmias by cardiac pacing. Heart, 78, 423-425.
9. PRIORI, S.G. (1998). Exploring the hidden danger of noncardiac drugs. J. Cardiovasc. Electrophysiol., 9, 1114-1116.
10. PRZYKLENK, K. & KLONER, R.A. (2001). Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis. J. Am. Coll. Cardiol., 37, 286-292.
11. QUI, Y., RIZVI, A., TANG, X.L., MANCHIKALAPUDI, S., TAKANO, H., JADOON, A.K., WU, W.-J. & BOLLI, R. (1997). Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am. J. Physiol., 273, H2931-H2936.
12. SALLOUM, F., YIN, C., XI, L. & KUKREJA, R.C. (2003). Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ. Res., 92, 595-597.
13. VÉGH, Á., KOMORI, S., SZEKERES, L. & PARRATT, J.R. (1992c). Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc. Res., 26, 486-495.
14. VÉGH, Á., PAPP, J.G. & PARRATT, J.R. (1994). Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br. J. Pharmacol., 113, 1081-1082.
15. VÉGH, Á., PAPP, J.G., SZEKERES, L. & PARRATT, J.R. (1992b). The local administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br. J. Pharmacol., 107, 910-911.
16. VÉGH, Á., SZEKERES, L. & PARRATT, J.R. (1992a). Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br. J. Pharmacol., 107, 448-452.
17. WALLIS, R.M. (1999). The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5. Nippon Yakurigaku Zasshi, 114 (Suppl. 1), 22P-26P.